Kevin Lobo Acquires 10,000 Shares of GE HealthCare Technologies (NASDAQ:GEHC) Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) Director Kevin Lobo bought 10,000 shares of GE HealthCare Technologies stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares of the company’s stock, valued at $921,817.34. This trade represents a 229.20% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC opened at $63.88 on Thursday. The business’s 50-day moving average price is $68.03 and its 200 day moving average price is $76.03. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a market capitalization of $29.06 billion, a PE ratio of 15.28, a price-to-earnings-growth ratio of 1.45 and a beta of 0.74. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter last year, the company posted $1.01 earnings per share. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of GEHC. Laurel Wealth Advisors LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $27,000. Godfrey Financial Associates Inc. purchased a new position in GE HealthCare Technologies in the fourth quarter valued at about $27,000. Montag A & Associates Inc. boosted its holdings in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC boosted its holdings in GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Piper Sandler dropped their price target on GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. BNP Paribas Exane dropped their price target on GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Evercore set a $80.00 price target on GE HealthCare Technologies in a research note on Thursday, April 30th. Wells Fargo & Company dropped their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Finally, Weiss Ratings lowered GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 15th. Nine analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.